Sabra Financial Statements From 2010 to 2025
| SBC Stock | EUR 15.42 0.69 4.28% |
Check Sabra Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sabra financial statements analysis is a perfect complement when working with Sabra Health Valuation or Volatility modules.
Sabra |
Sabra Health Care Company Return On Equity Analysis
Sabra Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sabra Health Return On Equity | -0.0241 |
Most of Sabra Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sabra Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sabra Health Care has a Return On Equity of -0.0241. This is 98.23% lower than that of the Real Estate sector and 100.28% lower than that of the REIT - Healthcare Facilities industry. The return on equity for all Germany stocks is 92.23% lower than that of the firm.
Sabra Health Care Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sabra Health's current stock value. Our valuation model uses many indicators to compare Sabra Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sabra Health competition to find correlations between indicators driving Sabra Health's intrinsic value. More Info.Sabra Health Care is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sabra Health's earnings, one of the primary drivers of an investment's value.About Sabra Health Financial Statements
Sabra Health stakeholders use historical fundamental indicators, such as Sabra Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sabra Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Health's assets and liabilities are reflected in the revenues and expenses on Sabra Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Health Care. Please read more on our technical analysis and fundamental analysis pages.
As of March 31, 2019, Sabras investment portfolio included 437 real estate properties held for investment 304 Skilled NursingTransitional Care facilities, 88 Senior Housing communities , 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements and 22 Specialty Hospitals and Other facilities, 30 assets held for sale, one investment in a direct financing lease, 20 investments in loans receivable one mortgage loan, two construction loans and 17 other loans, nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing Managed communities. As of March 31, 2019, Sabras real estate properties held for investment included 43,884 bedsunits and its unconsolidated joint venture included 7,652 bedsunits, spread across the United States and Canada
Currently Active Assets on Macroaxis
Other Information on Investing in Sabra Stock
Sabra Health financial ratios help investors to determine whether Sabra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabra with respect to the benefits of owning Sabra Health security.